Microfluidic Devices Market PowerPoint PPT Presentations

Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 to 2024. Microfluidic involves flow of liquid within micro-sized channels.

High number of research & development projects, increasing investments, and favorable regulatory policies are some other factors supporting growth of the market for pulmonary fibrosis treatment. Majority of the population living with pulmonary fibrosis is being treated with traditional corticosteroid combination drugs with limited efficacy. With the arrival of new novel therapies, unaddressed populations in middle- and lower-income countries, as well as developed countries, can offer significant revenue generation opportunities.

Global Microfluidic Devices Market size is projected to be valued $14 Billion by 2024; with a CAGR of 22.3% from 2017 to 2025. Microfluidics is an evolving scientific field with numerous analytical applications and commerci

Microfluidic Devices Market Share And Trends Analysis By Industry, Material, Application And Region - Forecast 2027

Global microfluidic device demand outlook looks impressive for the years ahead, with the market expected to top US$ 21.5 Bn by the end of 2031. This industry survey by Persistence Market Research expects the microfluidic devices market to surge at a CAGR of around 24% over the forecast period of 2021-2031.

Medical Microfluidic Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Microfluidic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Microfluidic devices are referred to as lithographic devices utilized for the diagnosis or analysis of small volumes of fluids to perform the chemical, physiological and biological procedures. Microfluidics devices are gaining popularity across extensive range of diagnostic applications because of need of extremely low quantity of samples and efficiency in data interpretation in comparison to the traditional laboratory equipment.

The Global And China Microfluidic Devices Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Devices industry.

The report Global Microfluidic Devices Industry 2016 Market Research Report covers the whole industry outlook with value chain analysis, DRO's, production and sales volumes and figures.

According to our new research study on “Micropump Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, material, application, end-user,” the market is expected to reach US$ 5,172.86 million by 2028 from US$ 1,553.01 million in 2021. A non-mechanical micropump employs forces directly on a liquid and have a limited flow rate, slower response compared to mechanical micropumps. However, they have shown to be very useful in drug delivery applications owing to their low power consumption. Non-mechanical micropumps are commonly used in micro devices because they can take advantage of physical properties of fluids when the volumes decrease to the micro-size and smaller.

The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.

The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The Microfluidic Devices Market Share is expected to reach USD 5,246.4 Million between 2021 at a CAGR of 22.8%.

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The microfluidics market is expected to witness market growth at a rate of 23.42% in the forecast period of 2022 to 2029. Data Bridge Market Research report on microfluidics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.

Market Size – USD 20.14 Billion in 2021, Market Growth – at a CAGR of 16.1%, Market Trends – Increasing application of microfluidic platforms in various healthcare industries

Microfluidics is a medical approach involving the precise control of small fluid samples for medical analysis. The sample sizes in microfluidics range from microliters to picolitres. At such low volumes, the transportation of fluid is governed significantly by its mass.

Microfluidic Sensors market size was valued at $1.4 billion in 2020, and it is estimated to grow at a CAGR of 6.9% during 2021-2026.

[258 Pages Report] Microfluidics Market categories the Global Market by Materials (Silicon, Polymers, Glass), Drug Delivery Devices (Microneedles, Micropumps), IVD (POC), Pharmaceuticals (Toxicity Screening, Microreactors, Proteomic & Genomic Analysis, Lab on Chip) & by Geography

The report Microfluidics Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The global microfluidics market size reached US$ 20.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2027, exhibiting a CAGR of 16.47% during 2022-2027. More info:- https://www.imarcgroup.com/microfluidics-market

According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market

According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market

Microfluidics Market size is estimated to reach US$ 43,398.7 million by 2027; it is estimated to grow at a CAGR of 17.9% from 2019 to 2027.

The global cell-free fetal DNA testing market is forecast to expand at a CAGR of 10% and thereby increase from a value of US$1.5 Bn in 2023, to US$2.9 Bn by the end of 2030.

Global Micro-Electro-Mechanical Systems (MEMS)

The Global Microfluidics Market report 2018-2024, has been prepared By Axiom Market Research & Consulting, based on a deep market analysis with inputs from industry experts. This report covers market landscape, strategies, merger & acquisition, size, key competitors, company profiles, progressive technological advancement, and expansion of production, segmentation, production, revenue and its growth prospects for the upcoming years.

Read here the latest updates on the U.S. BIOCHIP PRODUCT & SERVICES MARKET ANALYSIS published by CMI team.

This report studies the global microfluidics market over the forecast period of 2013 to 2018.The global microfluidics market is valued at $1.59 billion in 2013 and is poised to reach $3.57 billion by 2018, at a CAGR of 17.6%.

The Global And China Microfluidic Device Pumps Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device Pumps industry.

[258 Pages Report] Microfluidics Market categories the Global Market by Materials (Silicon, Polymers, Glass), Drug Delivery Devices (Microneedles, Micropumps), IVD (POC), Pharmaceuticals (Toxicity Screening, Microreactors, Proteomic & Genomic Analysis, Lab on Chip) & by Geography

With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach more than US$ 3,000 Mn in revenue and is estimated to grow 3.9x by 2026 end as compared to that in 2016. The point of care testing segment is the largest segment among the different application segments in the global microfluidics market, which was estimated to create close to US$ 1,000 Mn or 33.2% share of the total market in 2016. This segment is anticipated to register a CAGR of 14.5% over the forecast period.

The Point of Care Diagnostic Devices Market has changed the game because earlier, a medical sample had to be sent away from the patient for hours, sometimes for days, before the results were known. During this delay, the patient has to be treated without the necessary information.

Widefield Imaging Systems Market: Japan Regional Market Projected to Witness 2.1X Growth in Terms of Revenue over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The synthetic biology market is expected to exceed more than US$38 billion by 2020.

Lab-On-a-Chip Market report segments global market by application, end-user, product, and technology – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025

Hyperbaric oxygen therapy (HBOT) devices are used for delivering pure oxygen (100%) to tissues in the body under higher atmospheric pressure. Atmospheric pressure in hyperbaric oxygen chambers or devices is increased from one to three times higher than normal atmospheric pressure which in turns fight bacteria and also stimulates the release of a substance called growth factors and stem cells promoting healing.

BioMEMS devices deployed in hospitals and healthcare facilities are primarily focused on medical screening and diagnostic applications, such as devices that measure point-of-care parameters. Wearable devices that facilitate and assure continuous monitoring without hampering a user’s freedom of movement are being bolstered through new opportunities offered by innovative sensors for human biomedical signal acquisition coupled with wireless connectivity and low power solutions. In addition, greater attention is being accorded to diagnostic MEMS sensors that can assist in performing critical functions, such as cholesterol monitoring, pregnancy monitoring, food allergy detection and DNA analyses. Sensor technologies in several cases provide crucial outcomes and form a major element in the process of assisting in decision-making before obtaining formal clinical intervention and care.

The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/

The organ-on-chip market consists of sales of organs-on-chips by entities (organizations, sole traders and partnerships) that manufacture organs-on-chips used for drug development, toxicity testing, and personalized medicine research. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers containing multiple live human cells in a 3D culture that simulate key physiological functions of body organs. Organs-on-chips that mimic the organ level physiology of humans are a promising alternative to animal models.

The growing incidence of cardiovascular diseases and the technological developments in interventional cardiology devices are driving the demand of the market.

The global microfluidic devices market size was estimated to be US$ 13 billion in 2019 and is expected to grow at a CAGR of 10.8% through 2030. Microfluidic devices have emerged as a convenient and efficient solution for high throughput and low volume analysis of biochemical fluids. The demand for microfluidic devices is primarily driven by the rising adoption of point-of-care devices for efficient and quick assessment of wide range of medical conditions.

BioMEMS assimilate miniature sensors, actuators, micro-optics, microfluidics, and structural elements with computation and controls for application in the healthcare sector. Microsystems are used in the healthcare sector for numerous applications. These devices improve the performance of medical devices by providing a competitive advantage to medical device manufacturers. For instance, the use of accelerometers has improved the treatment of cardiac diseases. Another instance being the use of MEMS and nanotechnology to improve drug delivery. Global BioMEMS and Microsystem Market in the Healthcare sector to grow at a CAGR of 25.1% over the period 2014-2019. Read more details @ http://www.bigmarketresearch.com/global-biomems-and-microsystem-in-healthcare-2015-2019-market

Micro-Electro-Mechanical System (MEMS) Market by Sensor Type (Inertial, Pressure, Microphone, Micxrospeaker, Environmental Sensor, Optical Sensor), Actuator Type(Optical, Inkjet Head, Microfluidics and RF), Vertical and Region

Organ-On-Chip

Organ-On-Chip market development

Global paper diagnostics market size is expected to reach $14.49 Bn by 2028 at a rate of 9.7%, segmented as by product, dipsticks, lateral flow assays, paper based microfluidics

Micro-Electro-Mechanical Systems (MEMS) Market by Sensor Type (Inertial, Pressure, Microphone, Environmental, and Optical), Actuator Type (Optical, Inkjet Head, Microfluidics, and RF), Vertical, and Geography - Global Forecast to 2022

The Global Microfluidic Device Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device industry.

The application of microfluidic technologies and devices has been steadily ... A. F18 solution comes from a cyclotron, where 18F fluoride is produced via the ...

The Global Biochips Market held a market value of USD 7,300 million in 2017 and is projected to grow at a CAGR of 16.6% over the forecast period.

The rising incidence of hydrocephalus and increasing use of shunting procedures are driving the demand for the market.

The global medical device contract manufacturing market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product.